AzTrials
AzTrials

Prematurity; ExtremePREMA-NEUFNCT05684419

Preterm Infants Born to Homeless Mothers.

An observational study of Prematurity; Extreme, run by Hôpital NOVO at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In recent years, the number of homeless patients who are accommodated by the SAMU social has increased. These patients are in a situation of financial, but also often social and psychological precariousness. Read more about this study

Who is it for?
Ages Up to 33 weeks
Conditions the study is for
Prematurity; Extreme
What is being tested?
Fate and quality of medical follow-up of children born very premature (≤33SA) to homeless mothers
How many people
50 participants
Where
1 siteFrance
Study dates
29 Jul 2022to 12 Aug 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 33 weeks
  • All sexes
  • No healthy volunteers
  • Child

Study population: All infants born at or below 33SA: * Born between January 2019 and December 2021 * At the René Dubos Hospital in Pontoise * Whose mother did not have a fixed address at the time of discharge.

Who may be able to join

  • All infants born at or below 33SA:
  • Born between January 2019 and December 2021
  • At the René Dubos Hospital in Pontoise
  • Whose mother did not have a fixed address at the time of discharge.
  • NB: Mothers who do not read French well will have the study explained to them by the doctor who follows their child during a consultation, or by telephone.

Who cannot join

  • Opposition of the mothers

Trial locations and contacts

1 site in 1 country.

France1 site
  • Resuscitation and neonatal medicine department - Centre Hospitalier René Dubos

    Pontoise

Other trials in France

About this study

Official title: Observation of the Fate and Quality of Medical Follow-up of Children Born Preterm to Homeless Mothers.

In recent years, the number of homeless patients who are accommodated by the SAMU social has increased. These patients are in a situation of financial, but also often social and psychological precariousness. The literature already shows us that precariousness and homelessness are a risk factor for prematurity, but also for the patients themselves, a risk of more frequent recourse to emergency services and of late consultation for advanced pathologies.

The objective of this study is to evaluate the fate and quality of medical follow-up of children born very premature (≤33SA) to homeless mothers.

Read the detailed description

The hospital of Pontoise is the largest maternity hospital in the department (Val d'Oise, 95) with 4449 births in 2021. It has a type 3 neonatal intensive care unit where approximately 150 premature babies under 32 weeks of age are hospitalized each year, including 80 premature babies under 28 weeks of age. These children require a specific and prolonged follow-up after hospitalization, including medical consultations to evaluate their neurodevelopmental development, but also the prevention of RSV infection (Respiratory Syncitial Virus).

In recent years, the number of homeless patients who are accomodated by the SAMU social has increased. These patients are in a precarious financial, but also often social and psychological situation. The literature already shows us that precariousness and homelessness are a risk factor for prematurity, but also for the patients themselves, a risk of more frequent recourse to emergency services and late consultation with advanced pathologies.

The aim of this study is to evaluate the fate and quality of medical follow-up of children born very premature (≤33SA) to homeless mothers, by answering the following questions:

  • What about the follow-up of their very premature child?
  • How does the department organize itself to ensure optimal follow-up for these patients?
Being tested
Fate and quality of medical follow-up of children born very premature (≤33SA) to homeless mothers
Keywords
Premature, Homeless, Extreme prematurity
Medical subject headings
Premature Birth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fate and quality of medical follow-up of children born very premature (≤33SA) to homeless mothersOther

    Evaluation of the fate and quality of medical follow-up of children born very premature (≤33SA) to homeless mothers.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Assessment of the rate of infants born to homeless mothers at or below 33 SA and lost to follow-up for extreme prematurity

    Measurement of the number of children lost to follow-up at 12 months who missed their last follow-up appointment(s) organized in the context of prematurity, with no reason given or new schedule planned

    Measured: At 12 month

Secondary outcomes (7)
  1. Assessment of the compliance of homeless mothers with medical prescriptions and the respect of the instructions given for the course of care (treatments, physiotherapy, appointment scheduling, etc.)

    Measurement of the compliance rate of homeless mothers with medical prescriptions (treatments, physical therapy, appointment scheduling, etc.) at 12 months

    Measured: At 12 month

  2. Assessment of vaccination rates in infants born at or below 33 days' gestation to homeless mothers

    Measure of the number of children with full immunization among children born at 33 SA or less to homeless mothers at 12 months

    Measured: At 12 month

  3. Assessment of the organized follow-up in the city of infants born at a term less than or equal to 33 days of age, of homeless mothers (between the PMI and the attending physicians)

    Description of the type of organized follow-up in town of infants born at a term less than or equal to 33 days of age, of homeless mothers (between the PMI and the attending physicians, spacing of appointments), evaluated at 6 months

    Measured: At 6 month

  4. Assessment of the rate of re-hospitalization and consultation in the emergency room of the René Dubos Hospital for infants born at a term less than or equal to 33 days of age, of homeless mothers

    Measurement of the number of re-hospitalizations and emergency room visits at the René-Dubos Hospital for infants born at a term of less than or equal to 33 weeks of age, to homeless mothers, evaluated at 12 months

    Measured: At 12 month

  5. Assessment of breastfeeding duration at 6 months in infants born at or below 33 days' gestation to homeless mothers

    Measurement of breastfeeding duration in weeks, assessed at 6 months, in infants born at or below 33 SA to homeless mothers

    Measured: At 6 month

  6. Assessment of the type of feeding on the duration of follow-up in infants born at a term less than or equal to 33 SA, of homeless mothers

    Description of the type of feeding (breastfeeding, industrial milk, diversification) in infants born at a term less than or equal to 33 SA, of homeless mothers

    Measured: At 12 month

  7. Assessment of staturo-weight growth during follow-up in infants born at or below 33 SA born to homeless mothers

    Analysis of the staturo-weight growth curve (weight and Z score) in infants born at a term of less than or equal to 33 SA, to homeless mothers

    Measured: At 12 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jan 2023
  2. Study start29 Jul 2022
  3. Primary completion17 Jan 2023
  4. Study completion12 Aug 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05684419
Sponsor's protocol ID
CHRD0522
Acronym
PREMA-NEUF
Status last verified
Jan 2024
First submitted
16 Dec 2022
Last updated
19 Sep 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Prematurity; Extreme, run by Hôpital NOVO at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Assessment of the rate of infants born to homeless mothers at or below 33 SA and lost to follow-up for extreme prematurity (time frame: At 12 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in